95 results
Page 2 of 5
8-K
EX-10.1
cco8f
3 Jan 24
Departure of Directors or Certain Officers
4:05pm
10-K/A
EX-31.1
yja4wf2d vgy
9 Nov 23
Annual report (amended)
4:05pm
10-K/A
EX-31.2
tpp fs0a9avuvp
9 Nov 23
Annual report (amended)
4:05pm
8-K
EX-10.1
tc9m0903ddl
5 Sep 23
Xilio Therapeutics Announces Promotion of Katarina Luptakova, M.D., to Chief Medical Officer and Scott Coleman, Ph.D., to Chief Development Officer
8:35am
8-K
EX-99.2
ysmy3pfprcmb x22an
14 Aug 23
Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2023 Financial Results
7:40am
8-K
n63hv7wyeouitd
3 Aug 23
Departure of Directors or Certain Officers
4:15pm
8-K
EX-10.1
2ewsej969y1 4pgyj6
3 Aug 23
Departure of Directors or Certain Officers
4:15pm
8-K
EX-99.1
z3e1su xglowq5kwc
25 May 23
Regulation FD Disclosure
5:05pm